Justin Lee Grodin, MD
NPI 1750511820ActiveIndividual· Internal Medicine, Advanced Heart Failure and Transplant Cardiology· Dallas, TX
Internal Medicine, Advanced Heart Failure and Transplant Cardiology (MD) in Dallas, Texas, trained at University of Texas Southwestern Medical School at Dallas (class of 2009). Their prescriptions cost Medicare Part D more than their services did: $3,619,590 for 948 claims, against $43,711 paid for services in 2024. Novo Nordisk As was the largest of 5 companies reporting payments in 2025, $36,976 in all, mostly consulting fees.
Overview
| NPI | 1750511820 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Jul 22, 2009 |
| Last updated in NPPES | Aug 14, 2026 |
| Certified by provider | Aug 14, 2026 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Advanced Heart Failure and Transplant Cardiology Primary | 207RA0001X | N9561 | TX |
| Internal Medicine, Cardiovascular Disease | 207RC0000X | N9561 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Cardiovascular Disease (Cardiology) (TX) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 731 |
|---|---|
| Services billed | 1,147 across 15 procedure codes |
| Paid by Medicare | $43,711 |
Part D prescriptions in 2024
| Prescriptions (claims) | 948 · 1,603 30-day fills |
|---|---|
| Patients | 170 |
| Total drug cost | $3,619,590 |
| Generic share | 61% of claims |
Education and affiliations
| Medical school | University of Texas Southwestern Medical School at Dallas |
|---|---|
| Graduation year | 2009 |
| Medicare specialty | Cardiovascular Disease (Cardiology) |
| Secondary specialties | Internal Medicine |
| Telehealth | Offers telehealth |
Medical group
- University of Texas Southwestern Medical Center at DallasDallas, TX · 3,187 clinicians
Hospital affiliations
Industry payments (Open Payments)
- 2025$36,976 · 20 payments from 5 companies
- 2024$37,360 · 12 payments from 6 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Novo Nordisk As | $24,622 | 6 |
| Pfizer Inc. | $6,204 | 6 |
| Astrazeneca Pharmaceuticals LP | $3,748 | 5 |
| Alnylam Pharmaceuticals Inc. | $2,353 | 2 |
| Bridgebio Pharma, Inc. | $48.96 | 1 |
What the 2025 payments were for
- Consulting Fee$25,447 · 9 payments
- Travel and Lodging$10,545 · 3 payments
- Food and Beverage$983.80 · 8 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in Dallas
- 1972846285
- 1588906986
- 1205045184
- 1033118278
- 1285699009
- 1700976974
- 1386855922
- 1912961145
- 1174849566
- 1043606502
- 1518353911
- 1326571902
All Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in Texas →